AASLD – The Liver Meeting in Boston
Vivet Therapeutics is pleased to join AASLD – The Liver Meeting in Boston, MA this year. Meet with Vivet Therapeutics for an update on the GATEWAY gene therapy clinical trial for Wilson disease – booth B908
ESGCT’s 30th Annual Congress in Brussels
Excited to kick off ESGCT’s 30th Annual Congress in Brussels today! Join Vivet’s New Programs and Innovation Lead @Nicholas Weber, Ph.D. as he presents on the topic “Gene Therapy for Metabolic Diseases” on 25 October at 2:30 pm.
Vivet Therapeutics Announces Presentations at Upcoming European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
Paris, France, October 23, 2023 (GLOBE NEWSWIRE) – Vivet Therapeutics (“Vivet”), a clinical- stage biotechnology company
Wilson Disease Association’s Annual Conference
Vivet Therapeutics is delighted to sponsor and present at @Wilson Disease Association’s Annual Conference for patients and caregivers. Be sure to tune in to the presentation of CMO Bernard Benichou, MD, Ph.D, and Patient Advocate Lori McKenna Gorski!
